The Gastroparesis-GLP-1 Conflict
Gastroparesis — delayed gastric emptying — and GLP-1 medications have a fundamental tension: GLP-1s work partly by slowing gastric emptying. If your stomach already empties too slowly, adding a medication that slows it further can worsen symptoms (nausea, vomiting, bloating, abdominal pain) and potentially create medical complications.
For this reason, most prescribers treat active gastroparesis as a relative contraindication to GLP-1 therapy. But "relative" isn't "absolute." The clinical decision depends on the severity of your gastroparesis, whether it's currently active or historical, and what caused it.
Active vs. Historical Gastroparesis
Active gastroparesis with current symptoms: Starting a GLP-1 in this scenario is generally not recommended. Adding a gastric emptying delay on top of existing delayed emptying risks significant symptom worsening and potential complications like bezoar formation or severe dehydration from vomiting.
Historical gastroparesis that resolved: If your gastroparesis was caused by a reversible condition (medication-induced, post-surgical, infection-related) and you're currently asymptomatic with normal gastric emptying studies, your prescriber may consider GLP-1 therapy with closer monitoring and slower titration.
Diabetic gastroparesis: The most complex scenario. The patient needs blood sugar management (where GLP-1s excel) but has a GI condition that GLP-1s can worsen. This requires specialist input — usually a gastroenterologist and endocrinologist working together.
Embody
Top Pick — $400 CPA
From $249/mo
Injectable semaglutide only. Compounded — not FDA-approved.
Paid link Check Eligibility →If Your Prescriber Says Yes
If your prescriber determines that GLP-1 therapy is appropriate despite your gastroparesis history, expect a modified approach: slower titration (longer intervals between dose increases), lower target dose, more frequent monitoring, proactive antiemetic prescribing, and clear stop criteria — specific symptoms or severity thresholds that would trigger discontinuation.
You should also have a gastroenterologist in the loop, even if your GLP-1 is prescribed by a different provider. The gastroenterologist can monitor your GI function, order gastric emptying studies if symptoms emerge, and coordinate care with your GLP-1 prescriber.
If Your Prescriber Says No
If gastroparesis disqualifies you from GLP-1 therapy, ask about alternative approaches. Non-GLP-1 weight management medications (naltrexone/bupropion, phentermine/topiramate) don't slow gastric emptying. Bariatric surgery may be an option depending on the type and severity of your gastroparesis. Behavioral weight management programs provide non-pharmacologic approaches.
A denial based on gastroparesis is a clinical safety decision, not a bureaucratic one. If you believe the decision doesn't account for your specific situation (e.g., your gastroparesis resolved years ago), getting a second opinion from a gastroenterologist or obesity medicine specialist is appropriate.
Wellorithm
Science-Forward
From $199/mo
Compounded — not FDA-approved.
Paid link Check Eligibility →Sesame Care
Brand-Name Marketplace
From $99/visit
FDA-approved brand-name medications only (Wegovy, Zepbound, Foundayo). Not compounded.
Paid link Check Eligibility →